Biotech Values

[mcbio]

Gotcha. I am not positive how high the AZN royalties are, but in general I have been impressed with the financial value of these Astex Ltd deals...they seem to know how to drive a good bargain with the local UK pharma players...I will check my notes to see if I have any more color.

Thanks Andrew. People can point to the MRK/LGND BACE inhibitor and the Eisai BACE inhibitor being further along but given the enormous size and unmet need of the market, I'm sure there will be plenty of room for several players to make a dent in the market should BACE inhibitors pan out down the road. Obviously the AZN/Astex BACE inhibitor would need to be at least as good as the further along BACE inhibitors to effectively compete and there's no guarantee of that. But, at the same time, if this does prove true, you get ASTX due much more lucrative terms compared to LGND.